“After surviving a stroke, many patients don’t realize they can go on to develop this secondary condition and it’s important to understand the signs of spasticity as it can progress and worsen over ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...
SAN ANTONIO, Feb. 4, 2026 – For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, independence and quality of life. Often viewed as an ...
Four times a year, Marilyn Starcevich and her husband drive more than 400 miles from their home in Butte, Montana to Salt Lake City, Utah. Why? The Spasticity Management Program at Craig H. Neilsen ...
First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...
Vagus nerve stimulation (VNS) plus rehabilitation provided greater functional improvements compared with sham stimulation plus rehabilitation for patients with moderate to severe arm impairment after ...
Managing spasticity involves a comprehensive approach that combines medical treatments such as oral medications and Botox injections with daily self-care practices, including stretching, exercise, and ...